Anadys Pharmaceuticals

📍 United States👥 19 employees💰 Last funded Mar 2003
Medical Practices🌐 modapharma.com
Website LinkedIn
Anadys Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company dedicated to improving patient care by developing novel medicines in the areas of hepatitis C and oncology. For the treatment of chronic hepatitis C, the Company is developing two potentially complementary agents, ANA598, a non-nucleoside polymerase inhibitor and ANA773, an oral TLR7 agonist prodrug. The Company is also developing ANA773 for the treatment of cancer.
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
France
1
Frequently asked questions
Who invested in Anadys Pharmaceuticals?
Anadys Pharmaceuticals has 1 investors on record on gritt.io.
When did Anadys Pharmaceuticals last raise funding?
The most recent investment in Anadys Pharmaceuticals recorded on gritt.io was in March 2003.
What industry is Anadys Pharmaceuticals in?
Anadys Pharmaceuticals operates in Medical Practices. Find similar Medical Practices investors on gritt.io.
Where is Anadys Pharmaceuticals based?
Anadys Pharmaceuticals is headquartered in United States.